These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 8948063)
1. Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies. Simantov R; Lo SK; Salmon JE; Sammaritano LR; Silverstein RL Thromb Res; 1996 Dec; 84(5):361-5. PubMed ID: 8948063 [No Abstract] [Full Text] [Related]
2. Factor V Leiden, antiphospholipid antibodies and thrombosis in systemic lupus erythematosus. Fijnheer R; Horbach DA; Donders RC; Vilé H; von Oort E; Nieuwenhuis HK; Gmelig-Meijling FH; de Groot PG; Derksen RH Thromb Haemost; 1996 Oct; 76(4):514-7. PubMed ID: 8902988 [TBL] [Abstract][Full Text] [Related]
3. The Leiden mutation of coagulation factor V in Hungarian SLE patients. Regéczy N; Lakos G; Balogh I; Ajzner E; Kiss E; Szegedi G Clin Appl Thromb Hemost; 2000 Jan; 6(1):41-5. PubMed ID: 10726048 [TBL] [Abstract][Full Text] [Related]
8. Risk of thrombosis in patients with antiphospholipid antibodies and factor V Leiden mutation. Pablos JL; Caliz RA; Carreira PE; Atsumi T; Serrano L; Amengual O; Santiago B; Khamashta MA; Hughes GR; Gomez-Reino JJ J Rheumatol; 1999 Mar; 26(3):588-90. PubMed ID: 10090167 [TBL] [Abstract][Full Text] [Related]
9. Thrombotic events in systemic lupus erythematosus. Its association with acquired and inherited thrombophilic defects. Vayá A; Santaolaria M; Micó L; Calvo J; Oropesa R; Villa P; Todoli J; Simó M; Corella D; Ricart JM Clin Hemorheol Microcirc; 2008; 40(2):79-87. PubMed ID: 19029633 [TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies. Viveros ME; Cabiedes J; Reyes E; Cabral AR Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641 [TBL] [Abstract][Full Text] [Related]
11. Lupus anticoagulant, factor V Leiden, and methylenetetrahydrofolate reductase gene mutation in a lupus patient with cerebral venous thrombosis. Uthman I; Khalil I; Sawaya R; Taher A Clin Rheumatol; 2004 Aug; 23(4):362-3. PubMed ID: 15293102 [TBL] [Abstract][Full Text] [Related]
12. Variable plasma levels of Factor V Leiden correlate with circulating platelet microparticles in carriers of Factor V Leiden. Lincz LF; Scorgie FE; Enjeti A; Seldon M Thromb Res; 2012 Feb; 129(2):192-6. PubMed ID: 21798575 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. DeSancho MT; Berlus N; Christos PJ; Rand J Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699 [TBL] [Abstract][Full Text] [Related]
14. Thrombosis of vascular access associated with factor V Leiden, antiphospholipid antibodies and antiheparin antibodies in a young woman on dialysis receiving warfarin following mitral valve replacement. Molino D; De Lucia D; Perna AF; Cirillo M; De Santo NG Nephrol Dial Transplant; 2006 Jun; 21(6):1719-20. PubMed ID: 16476715 [No Abstract] [Full Text] [Related]
15. Prospective evaluation of the prevalence of factor V Leiden mutation in portal or hepatic vein thrombosis. Denninger MH; Helley D; Valla D; Guillin MC Thromb Haemost; 1997 Oct; 78(4):1297-8. PubMed ID: 9365003 [No Abstract] [Full Text] [Related]
16. Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis. Salem HH Lupus; 1996 Apr; 5(2):163-6. PubMed ID: 8743134 [No Abstract] [Full Text] [Related]
17. Renal colic in a patient with anti-phospholipid antibodies and factor V Leiden mutation. Klein O; Bernheim J; Strahilevitz J; Lehmann J; Korzets Z Nephrol Dial Transplant; 1999 Oct; 14(10):2502-4. PubMed ID: 10528686 [No Abstract] [Full Text] [Related]
18. Clinical significance of acquired activated protein C resistance in patients with systemic lupus erythematosus. Muñoz-Rodríguez FJ; Reverter JC; Font J; Tàssies D; Espinosa G; Cervera R; Carmona F; Balsch J; Ingelmo M; Ordinas A Lupus; 2002; 11(11):730-5. PubMed ID: 12475003 [TBL] [Abstract][Full Text] [Related]
19. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome. Dizon-Townson D; Hutchison C; Silver R; Branch DW; Ward K Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406 [TBL] [Abstract][Full Text] [Related]
20. Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Jiménez S; Tàssies D; Espinosa G; García-Criado A; Plaza J; Monteagudo J; Cervera R; Reverter JC Ann Rheum Dis; 2008 Jun; 67(6):835-40. PubMed ID: 17728329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]